Details for New Drug Application (NDA): 063165
✉ Email this page to a colleague
NDA 063165 describes ADRIAMYCIN PFS, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the ADRIAMYCIN PFS profile page.
The generic ingredient in ADRIAMYCIN PFS is doxorubicin hydrochloride. There are seventeen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the doxorubicin hydrochloride profile page.
The generic ingredient in ADRIAMYCIN PFS is doxorubicin hydrochloride. There are seventeen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the doxorubicin hydrochloride profile page.
Summary for 063165
| Tradename: | ADRIAMYCIN PFS |
| Applicant: | Pfizer |
| Ingredient: | doxorubicin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063165
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
| Approval Date: | Jan 30, 1991 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/100ML | ||||
| Approval Date: | Jan 30, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
